维普中文期刊产品整合服务
59篇 您的检索式:作者名="Gooding WE"
    题名 作者 年代 出处 被引量
11,1 vivo antitumor effi cacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy显示文摘Xi S Gooding WE Grandis JR 2005Oncogene2005,24,6:1
2Levels of TGF- alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival显示文摘Rubin Grandis J Melhem MF Gooding WE 1998J Natl Cancer Inst1998,90,11:1
3Outcomes ofsublobar resection versus lobectomy for stage I non-smallcell lung cancer:a 13-year analysis显示文摘El-Sherif A Gooding WE Santos R 2006Ann Thorac Surg2006,82,2:1
4Fecal incontinence in US adults:epidemiology and risk factors显示文摘Whitehead WE Borrud L Goode PS Pelvic FloorDisorders Network 2009Gastroenterology2009,137,2:1
5Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer 显示文摘Argiris A Karamouzis MV Gooding WE 2011J Clin Oncol2011,29,9:1
6Fecalincontinence in US adults: epidemiology and risk factors 显示文摘Whitehead WE Borrud L Goode PS 2009Gastroenterology2009,137,:1
7Levels ofTGF-alpha and EGFR protein in head and neck squamous cellcarcinoma and patient survival显示文摘Rubin Grandis J Melhem MF Gooding WE 1998J Natl Cancer Inst1998,90,11:1
8Biological response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients显示文摘 Gooding WE Whiteside TL 1997J Immunother1997,20,5:1
9Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer:results and possible immune system-related mechanisms显示文摘Levitt ML Kassem B Gooding WE et a1 2004Lung Cancer2004,43,3:1
10Levels of TGF -alpha and EGFR protein in head and neck squamous cellcarcinoma and patient survival 显示文摘Rubin GJ Melhem MF Gooding WE 1998J Natl Cancer Inst1998,,:1
11Constitutive activation of Stat5bcontributes to carcinogenesis in vivo显示文摘Xi S Zhang Q Gooding WE 2003Cancer Res2003,63,20:1
12Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma显示文摘Lew JI Gooding WE Ribeiro U Jr 2001Arch Surg2001,136,7:1
13Outcomes of sublo- bar rcsec - tion versus lobectony for stage I non - small cell lung cancer : a 13 - year analysis 显示文摘E1 - Sherif A Gooding WE Santos R 2006Ann Thorac Surg2006,82,2:1
14In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach:implications for cancer therapy显示文摘Xi S Gooding WE Grandis JR 2005Oncogene2005,24,6:1
15Levels of TGF -α and EGFR protein in head and neck squamous cell carcinoma and patient survival显示文摘Grandis JR Melhen MF Gooding WE 1998J Nail Cancer Inst1998,90,11:1
16Outcomes of sublobar re- section versus lobectomy for stage I nonsmall cell lung cancer: a 13- year analysis显示文摘E1-Sherif A Gooding WE Santos R 2006Ann Thorac Surg2006,82,2:1
17Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients显示文摘Logan TF Gooding WE Whiteside TL 1997J Immunother1997,20,5:1
18Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes 显示文摘Seethala RR Gooding WE Handler PN 2008Clin Cancer Res2008,14,5:1
19Constitutive activalion of Stat5b contributes to carcinogenesis in vivo显示文摘Xi S Zhang Q Gooding WE 2003Cancer Res2003,63,20:1
20Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis显示文摘E1-Sherif A Gooding WE Santos R 2006Ann Thorac Surg2006,82,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费